Search research articles
Contact Us
Filters
Showing results (11-20 of 77) with videos related to
Page
of 8
Sort By:
Current Medical Research and Opinion
|
October 12, 2020
Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia
Qing Huang, Bruno Emond, Marie-Hélène Lafeuille, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 27, 2017
Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide
Dominic Pilon, Ajay S Behl, Lorie A Ellis, et al.
Journal of Medical Economics
|
March 15, 2022
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer
Julie Vanderpoel, Andrea L Stevens, Bruno Emond, et al.
Journal of Drugs in Dermatology : JDD
|
February 21, 2018
Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis
Amy S Paller, Rakesh Singh, Martin Cloutier, et al.
Journal of Health Economics and Outcomes Research
|
June 28, 2021
Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
Bruno Emond, Carmine Rossi, Aurélie Côté-Sergent, et al.
Pharmacoeconomics - Open
|
April 19, 2023
Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis
Julie Vanderpoel, Bruno Emond, Isabelle Ghelerter, et al.
Patient Preference and Adherence
|
March 31, 2017
Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
Dominic Pilon, Kruti Joshi, Neeta Tandon, et al.
Current Medical Research and Opinion
|
January 28, 2021
Risk of subsequent relapses and corresponding healthcare costs among recently-relapsed Medicaid patients with schizophrenia: a real-world retrospective cohort study
Charmi Patel, Bruno Emond, Laura Morrison, et al.
Biologics : Targets & Therapy
|
January 14, 2021
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
Timothy Fitzgerald, Richard Melsheimer, Marie-Hélène Lafeuille, et al.
Current Medical Research and Opinion
|
May 18, 2021
Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax
Kerry A Rogers, Bruno Emond, Ameur M Manceur, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 77) with videos related to
Sort By:
Page
of 8
Current Medical Research and Opinion
|
October 12, 2020
Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia
Qing Huang, Bruno Emond, Marie-Hélène Lafeuille, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 27, 2017
Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide
Dominic Pilon, Ajay S Behl, Lorie A Ellis, et al.
Journal of Medical Economics
|
March 15, 2022
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer
Julie Vanderpoel, Andrea L Stevens, Bruno Emond, et al.
Journal of Drugs in Dermatology : JDD
|
February 21, 2018
Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis
Amy S Paller, Rakesh Singh, Martin Cloutier, et al.
Journal of Health Economics and Outcomes Research
|
June 28, 2021
Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
Bruno Emond, Carmine Rossi, Aurélie Côté-Sergent, et al.
Pharmacoeconomics - Open
|
April 19, 2023
Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis
Julie Vanderpoel, Bruno Emond, Isabelle Ghelerter, et al.
Patient Preference and Adherence
|
March 31, 2017
Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
Dominic Pilon, Kruti Joshi, Neeta Tandon, et al.
Current Medical Research and Opinion
|
January 28, 2021
Risk of subsequent relapses and corresponding healthcare costs among recently-relapsed Medicaid patients with schizophrenia: a real-world retrospective cohort study
Charmi Patel, Bruno Emond, Laura Morrison, et al.
Biologics : Targets & Therapy
|
January 14, 2021
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
Timothy Fitzgerald, Richard Melsheimer, Marie-Hélène Lafeuille, et al.
Current Medical Research and Opinion
|
May 18, 2021
Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax
Kerry A Rogers, Bruno Emond, Ameur M Manceur, et al.
Page
of 8